Thomas Stephen Basil

DirectorClimb Bio, Inc. (CLYM) · full profile →Form 4 · filed Feb 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$350K
Net Open-Market Flow
-$350K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2026Sell(S)16K$7.01$114K155K
Feb 25, 2026Sell(S)34K$7.00$236K171K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-082533) within minutes of acceptance. Every field above traces to the original document. Verify it directly: